Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) just unveiled an update.
Lifecare ASA has reminded investors that subscription rights in its ongoing partially underwritten rights issue, aimed at raising gross proceeds of between NOK 80 million and NOK 100 million, will be suspended from trading on Euronext Oslo Børs at 16:30 CET on 15 January 2026. Holders are warned that any subscription rights not exercised by 16:30 CET on 21 January 2026, or sold before trading suspension, will lapse without compensation, a deadline that could materially affect existing shareholders’ ability to participate in the financing and avoid dilution.
More about Lifecare AS
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a core focus on bringing next‑generation continuous glucose monitoring systems to market. The company’s proprietary sensor technology, based on osmotic pressure as the sensing principle, is designed to detect and monitor a broad range of analytes and molecules in humans and pets, positioning Lifecare within the growing market for advanced digital health and diagnostics solutions.
Average Trading Volume: 534,413
Current Market Cap: NOK164.3M
For an in-depth examination of LFC0 stock, go to TipRanks’ Overview page.